These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

825 related items for PubMed ID: 14593958

  • 1. [Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease].
    Kłosiewicz-Latoszek L, Respondek W, Białobrzeska-Paluszkiewicz J, Grzybowska B, Jakóbisiak-Ostasz B, Stolarska I.
    Pol Merkur Lekarski; 2003 Jul; 15(85):42-6. PubMed ID: 14593958
    [Abstract] [Full Text] [Related]

  • 2. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [Abstract] [Full Text] [Related]

  • 3. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.
    Goldberg AC, Bittner V, Pepine CJ, Kelly MT, Thakker K, Setze CM, Lele A, Sleep DJ.
    Am J Cardiol; 2011 Mar 15; 107(6):898-905. PubMed ID: 21247520
    [Abstract] [Full Text] [Related]

  • 5. Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy.
    Farnier M, Ducobu J, Bryniarski L.
    Curr Med Res Opin; 2011 Nov 15; 27(11):2165-73. PubMed ID: 21973199
    [Abstract] [Full Text] [Related]

  • 6. Pharmacoepidemiology safety study of fibrate and statin concomitant therapy.
    Enger C, Gately R, Ming EE, Niemcryk SJ, Williams L, McAfee AT.
    Am J Cardiol; 2010 Dec 01; 106(11):1594-601. PubMed ID: 21094360
    [Abstract] [Full Text] [Related]

  • 7. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'.
    Devroey D, Velkeniers B, Duquet W, Betz W.
    Int J Cardiol; 2005 May 25; 101(2):231-5. PubMed ID: 15882669
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
    Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M, LCP-AtorFen Investigators.
    Clin Ther; 2009 Dec 25; 31(12):2824-38. PubMed ID: 20110022
    [Abstract] [Full Text] [Related]

  • 9. [Long-term hypolipidemic treatment of mixed hyperlipidemia with a combination of statins and fibrates].
    Zeman M, Zák A, Vecka M, Romaniv S.
    Cas Lek Cesk; 2003 Aug 25; 142(8):500-4. PubMed ID: 14626567
    [Abstract] [Full Text] [Related]

  • 10. [Combination of pravastatin and fenofibrate (Pravafenix ®). Safety studies].
    Hernández Mijares A.
    Clin Investig Arterioscler; 2014 Jul 25; 26 Suppl 1():25-30. PubMed ID: 25043544
    [Abstract] [Full Text] [Related]

  • 11. Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations.
    Hamilton-Craig I, Kostner KM, Woodhouse S, Colquhoun D.
    Int J Evid Based Healthc; 2012 Sep 25; 10(3):181-90. PubMed ID: 22925614
    [Abstract] [Full Text] [Related]

  • 12. [The fixed combination of pravastatin and fenofibrate: what can it provide?].
    Díaz Rodríguez Á.
    Clin Investig Arterioscler; 2014 Jul 25; 26 Suppl 1():12-6. PubMed ID: 25043541
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy and safety of combination therapy with simvastatin and fenofibrate for combined hyperlipidemia].
    Ren JY, Chen H, Luo Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb 25; 33(2):122-6. PubMed ID: 15924805
    [Abstract] [Full Text] [Related]

  • 14. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population.
    Amend KL, Landon J, Thyagarajan V, Niemcryk S, McAfee A.
    Ann Pharmacother; 2011 Oct 25; 45(10):1230-9. PubMed ID: 21917557
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis.
    Choi HD, Shin WG.
    Curr Med Res Opin; 2014 Jan 25; 30(1):1-10. PubMed ID: 24063624
    [Abstract] [Full Text] [Related]

  • 16. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW.
    Curr Med Res Opin; 2001 Jan 25; 17(1):60-73. PubMed ID: 11464448
    [Abstract] [Full Text] [Related]

  • 17. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 25; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of adding fenofibrate 160 mg in high-risk patients with mixed hyperlipidemia not controlled by pravastatin 40 mg monotherapy.
    Farnier M, Ducobu J, Bryniarski L.
    Am J Cardiol; 2010 Sep 15; 106(6):787-92. PubMed ID: 20816118
    [Abstract] [Full Text] [Related]

  • 19. Adverse events following statin-fenofibrate therapy versus statin alone: a meta-analysis of randomized controlled trials.
    Geng Q, Ren J, Chen H, Lee C, Liang W.
    Clin Exp Pharmacol Physiol; 2013 Mar 15; 40(3):219-26. PubMed ID: 23324122
    [Abstract] [Full Text] [Related]

  • 20. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R, Mahajan M, Singh B, Bal BS, Kant R.
    J Indian Med Assoc; 2006 Sep 15; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.